Crain’s Daily Gist: FDA blesses AbbVie’s new drug

—Credit: AbbVie —Cutline: AbbVie’s North Chicago headquarters

The approval could help the North Chicago pharma firm replace revenue from its blockbuster Humira. Plus:Boeing suspends its forecast, McDonald’s turns up the pressure on Uber ahead of its IPO, Ford invests in electric truck maker Rivian, and more.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.